Find a Tender
complete
Official procurement procedure
Novosorb Biodegradable Temporizing Matrix (BTM)
Dressings
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The Newcastle Upon Tyne Hospitals NHS Foundation Trust: "Novosorb Biodegradable Temporizing Matrix (BTM)". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | The Newcastle Upon Tyne Hospitals NHS Foundation Trust | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: The Newcastle Upon Tyne Hospitals NHS Foundation Trust
Market Analytics
Derived from OCDS awards & bid statistics
Published history for The Newcastle Upon Tyne Hospitals NHS Foundation Trust. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
2.3Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 29 active published awards; 24 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityThe Newcastle Upon Tyne Hospitals NHS Foundation Trust | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published15 Feb 2024, 09:52 GMT | Last source update15 Feb 2024, 09:52 GMT | Recurring procurementNot published |
ClassificationDressings | ||
Delivery area | ||
OCIDocds-h6vhtk-043a4b | ||
What is being bought
Novosorb Biodegradable Temporizing Matrix (BTM)
What changed
From the official release history
- Status changed to complete
15 Feb 2024, 09:52 GMT - Official notice release published
15 Feb 2024, 09:52 GMT - Buyer information updated
15 Feb 2024, 09:52 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedStatus not publishedPublished valueNot publishedNovosorb Biodegradable Temporizing Matrix (BTM) Additional information: Supply of Novosorb Biodegradable Temporizing Matrix (BTM) via consignment agreement from Polynovo, but delivered by distributor MoviantoContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
15 Feb 2024, 09:52 GMT - Award active
Not published · Not published - Contract active
Signed 14 Feb 2024, 00:00 GMT · £200,000
Commercial outcome and competition
Awards Movianto UK Limited Not published · Not published · active |
Contracts Contract £200,000 · signed 14 Feb 2024, 00:00 GMT · active |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
The Newcastle Upon Tyne Hospitals NHS Foundation Trust
Contracting authority GB-FTS-79645Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationalePolynovo is the only supplier of this product and this is the only synthetic dermal template available worldwide. The advantage above other dermal matrices, such as Integra, is that this product is very resistant to infection. Therefore low risk of it getting infected and needing removal. I have not lost a single piece of BTM from infection. <br/><br/>The clinical advantage for burns patients is earlier engagement in physiotherapy, less pain (and painkillers) and better long term scar quality. If the scars are better longterm, they need less scar therapy, less reconstruction and have better quality of life. Other teams are using this for complex wound reconstruction as an alternative to free flap surgery, which can take up to 12 hours. This takes significantly less time to apply, saving theatre time and allowing patients to be discharged earlier from hospital, with less invasive surgery. |